Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: A comparative analysis of response to treatment and predictors of outcome

Journal of Oral Pathology and Medicine

Volumn 41, Issue 3, 2012, Pages 222-228

  Fortuna, Giulio ^a,b   Ruoppo, Elvira ^b   Pollio, Annamaria ^b   Aria, Massimo ^c   Adamo, Daniela ^b   Leuci, Stefania ^b   Orabona, Giovanni Dell'Aversana ^b   Mignogna, Michele D ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Breast cancer; Clinical remission; Multiple myeloma; Osteonecrosis of the jaws; Treatment

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; SULTAMICILLIN; ZOLEDRONIC ACID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BISPHOSPHONATE RELATED OSTEONECROSIS; BREAST CANCER; CANCER PAIN; CANCER PATIENT; CANCER REGRESSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; JAW OSTEONECROSIS; MALE; MULTIPLE MYELOMA; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT RESPONSE;

AGED; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; IMIDAZOLES; MALE; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; PAIN MEASUREMENT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME; WOUND HEALING;

EID: 84857783181     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01095.x     Document Type: Article

References (21)

1. Almazrooa SA, Woo SB. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc 2009; 140: 864-75.
2. Kyrgidis A, Vahtsevanos K, Koloutsos G, et al. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol 2008; 26: 4634-48.
3. Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 2009; 20: 331-6.
4. Sambrook P, Olver I, Goss A. Bisphosphonates and osteonecrosis of the jaw. Aust Fam Physician 2006; 35: 801-3.
5. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update. J Oral Maxillofac Surg 2009; 67: 2-12.
6. Park W, Kim NK, Kim MY, Rhee YM, Kim HJ. Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int 2010; 21: 527-33.
7. Hong JW, Nam W, Cha IH, et al. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int 2010; 21: 847-53.
8. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007; 29: 1548-58.
9. Yoneda T, Hagino H, Sugimoto T, et al. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 2010; 28: 365-83.
10. Mawardi H, Treister N, Richardson P, et al. Sinus tracts - an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 2009; 67: 593-601.
11. Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007; 22: 1479-91.
12. Khan AA, Sandor GK, Dore E, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008; 35: 1391-7.
13. Fedele S, Porter SR, D'Aiuto F, et al. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 2010; 123: 1060-4.
14. Rustemeyer J, Bremerich A. Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature Clin Oral Investig 2010; 14: 59-64.
15. Kyrgidis A, Koloutsos G, Vahtsevanos K. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws. Head Neck 2009; 31: 1112-3.
16. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs 2005; 14: 798-804.
17. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005; 23: 8580-7.
18. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006; 24: 945-52.
19. Badros A, Terpos E, Katodritou E, et al. Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 2008; 26: 5904-9.
20. Pozzi S, Marcheselli R, Falorio S, et al. Bisphosphonates-associated osteonecrosis of the jaw: a long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time. Am J Hematol 2009; 84: 850-2.
21. Magopoulos C, Karakinaris G, Telioudis Z, et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 2007; 28: 158-63.